South Tees Hospitals NHS Foundation Trust
Expenditure
High Spend Suppliers
-
HMRC
£428.7M 28.0% share -
ENDEAVOUR SCH PLC
£282.6M 18.5% share -
Sccl (101 Consumables)
£116.7M 7.6% share -
Nhcft - Lead Employer Trust
£111.8M 7.3% share -
Nhsresolution
£69.3M 4.5% share -
NHS PROFESSIONALS LIMITED
£56.9M 3.7% share -
SCCL (201 MAINTENANCE)
£46.1M 3.0% share -
Integrated Health Projects
£34.4M 2.3% share -
NHS PROPERTY SERVICES LIMITED
£30.3M 2.0% share -
Northumbria Healthcare NHS Foundation Trust
£29.5M 1.9% share
Top Expense Areas
2026-01-01 to 2026-01-31
-
Balance Sheet
£25.9M -
Pharmacy Stores Suspense
£3.2M -
Cnst / Insurance
£2.3M -
Property & Utilities
£1.6M -
Salix Grant
£1.6M
Top Expense Types
2026-01-01 to 2026-01-31
-
Payables < One Year
£24.6M -
Tangible Fixed Assets
£3.8M -
General Supplies & Service
£3.7M -
Inventory
£3.2M -
Clinical Supplies & Services
£2.3M
Recent Payments Out
| Date | Supplier | Amount | Expense Area | Expense Type | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-01-29 | £431,654 | Property & Utilities | Premises | ||||||||
| Rent | |||||||||||
| 2026-01-29 | £31,238 | Pharmacy Stores Suspense | Inventory | ||||||||
| Stocks And Work In Progress | |||||||||||
| 2026-01-29 | £98,839 | Pharmacy Stores Suspense | Inventory | ||||||||
| Stocks And Work In Progress | |||||||||||
| 2026-01-29 | £25,249 | Property & Utilities | Premises | ||||||||
| Rent | |||||||||||
| 2026-01-29 | £25,107 | Pharmacy Stores Suspense | Inventory | ||||||||
| Stocks And Work In Progress | |||||||||||
| 2026-01-29 | £26,319 | Renal Medicine | Drugs | ||||||||
| Renal Fluids | |||||||||||
| 2026-01-29 | £26,568 | Pharmacy Stores Suspense | Inventory | ||||||||
| Stocks And Work In Progress | |||||||||||
| 2026-01-29 | £26,568 | Pharmacy Stores Suspense | Inventory | ||||||||
| Stocks And Work In Progress | |||||||||||
| 2026-01-29 | £30,000 | Pharmacy Stores Suspense | Inventory | ||||||||
| Stocks And Work In Progress | |||||||||||
| 2026-01-29 | £30,069 | Respiratory Medicine | General Supplies & Service | ||||||||
| Other Gen Supplies & Services | |||||||||||
| 2026-01-29 | £36,628 | Cellular Pathology | Clinical Supplies & Services | ||||||||
| Laboratory External Tests | |||||||||||
| 2026-01-29 | £46,196 | Property & Utilities | Premises | ||||||||
| Rent | |||||||||||
| 2026-01-29 | £62,505 | Central Transactions | Premises | ||||||||
| Rent | |||||||||||
| 2026-01-29 | £39,195 | Cellular Pathology | Clinical Supplies & Services | ||||||||
| Laboratory External Tests | |||||||||||
| 2026-01-29 | £40,717 | Pharmacy Stores Suspense | Inventory | ||||||||
| Stocks And Work In Progress | |||||||||||
| 2026-01-29 | £471,630 | Balance Sheet | Payables < One Year | ||||||||
| Nhs Payable Nhs Supply Chain | |||||||||||
| 2026-01-29 | £392,169 | Balance Sheet | Payables < One Year | ||||||||
| Nhs Payable Nhs Professionals | |||||||||||
| 2026-01-29 | £141,465 | It Kit Replacement | Tangible Fixed Assets | ||||||||
| Assets Under Const. Nbv B/F | |||||||||||
| 2026-01-29 | £117,857 | Trauma & Orthopaedics | Clinical Supplies & Services | ||||||||
| Other Clinical Costs | |||||||||||
| 2026-01-29 | £653,749 | Property & Utilities | Premises | ||||||||
| Rent | |||||||||||
Showing 1 to 20 of 4847 transactions
Recent Payments In
| Date | Buyer | Amount | Expense Area | Expense Type | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-09-25 | £26,105 | Science and Research | Research & development | ||||||||
| HTA Surgery and Medical Devices | |||||||||||
| 2025-09-25 | £59,999 | Science and Research | Research & development | ||||||||
| Research for patients benefit programme (RFPB) | |||||||||||
| 2025-09-25 | £82,761 | Science and Research | Research & development | ||||||||
| HTA Pharmaceuticals and Gene Therapy | |||||||||||
| 2025-09-25 | £109,618 | Science and Research | Research & development | ||||||||
| Research Capability Funding - Standard | |||||||||||
| 2025-09-25 | £88,977 | Science and Research | Research & development | ||||||||
| HTA Other Therapeutic Interventions | |||||||||||
| 2025-09-25 | £85,851 | Science and Research | Research & development | ||||||||
| HTA Surgery and Medical Devices | |||||||||||
| 2025-09-25 | £70,568 | Science and Research | Research & development | ||||||||
| HTA Surgery and Medical Devices | |||||||||||
| 2025-08-04 | £108,553 | Strategic Command | Administration Pmnts+Cash loss | ||||||||
| Administration Pmnts | |||||||||||
| 2025-08-04 | £96,607 | Strategic Command | Med/Welfare/Soc+Rec Costs | ||||||||
| Medical Costs | |||||||||||
| 2025-07-09 | £44,339 | Chief Scientific Adviser | Research & development | ||||||||
| Research for patients benefit programme (RFPB) | |||||||||||
| 2025-06-30 | £109,618 | Chief Scientific Adviser | Research & development | ||||||||
| Research Capability Funding - Standard | |||||||||||
| 2025-06-25 | £74,710 | Chief Scientific Adviser | Research & development | ||||||||
| HTA Pharmaceuticals and Gene Therapy | |||||||||||
| 2025-06-25 | £26,105 | Chief Scientific Adviser | Research & development | ||||||||
| HTA Surgery and Medical Devices | |||||||||||
| 2025-06-25 | £87,750 | Chief Scientific Adviser | Research & development | ||||||||
| HTA Other Therapeutic Interventions | |||||||||||
| 2025-06-25 | £109,119 | Chief Scientific Adviser | Research & development | ||||||||
| HTA Surgery and Medical Devices | |||||||||||
| 2025-06-25 | £70,568 | Chief Scientific Adviser | Research & development | ||||||||
| HTA Surgery and Medical Devices | |||||||||||
| 2025-04-10 | £82,315 | Chief Scientific Adviser | Research & development | ||||||||
| HTA Surgery and Medical Devices | |||||||||||
| 2025-03-20 | £53,498 | Chief Scientific Adviser | Research & development | ||||||||
| HTA Surgery and Medical Devices | |||||||||||
| 2025-03-20 | £109,119 | Chief Scientific Adviser | Research & development | ||||||||
| HTA Surgery and Medical Devices | |||||||||||
| 2025-03-20 | £73,613 | Chief Scientific Adviser | Research & development | ||||||||
| HTA Surgery and Medical Devices | |||||||||||
Showing 1 to 20 of 1122 transactions
Frequently Asked Questions
What is the latest spending data available for South Tees Hospitals NHS Foundation Trust?
The most recent spending data we have available for South Tees Hospitals NHS Foundation Trust is from January 2026. Government departments and public bodies typically publish their spending data on a monthly or quarterly basis.
How has South Tees Hospitals NHS Foundation Trust's spending changed over time?
South Tees Hospitals NHS Foundation Trust's spending has decreased over time. In 2026, they spent £43,582,422, compared to £550,666,611 in 2025 - a decrease of 92.1%.
How much does South Tees Hospitals NHS Foundation Trust spend on suppliers?
South Tees Hospitals NHS Foundation Trust has spent a total of £1,528,795,675 on suppliers according to our records. This spending is distributed across 317 suppliers.